✦ LIBER ✦

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

✍ Scribed by Tameris, Michele D; Hatherill, Mark; Landry, Bernard S; Scriba, Thomas J; Snowden, Margaret Ann; Lockhart, Stephen; Shea, Jacqueline E; McClain, J Bruce; Hussey, Gregory D; Hanekom, Willem A; Mahomed, Hassan; McShane, Helen

Book ID: 119976547
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 316 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(13)60177-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a recombinant hep

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

✍ Feng-Cai Zhu; Jun Zhang; Xue-Feng Zhang; Cheng Zhou; Zhong-Ze Wang; Shou-Jie Hua 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 272 KB

Immunogenicity and safety of an enterovi

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

✍ Zhu, Feng-Cai; Liang, Zheng-Lun; Li, Xiu-Ling; Ge, Heng-Ming; Meng, Fan-Yue; Mao 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 166 KB

Clinical efficacy and safety of a novel

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

✍ Capeding, Maria Rosario; Tran, Ngoc Huu; Hadinegoro, Sri Rezeki S; Ismail, Hussa 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 435 KB

Safety and efficacy of the peptide-based

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

✍ Pollard, Richard B; Rockstroh, Jürgen K; Pantaleo, Giuseppe; Asmuth, David M; Pe 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 458 KB

Safety, immunogenicity, and tolerability

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

✍ Richmond, Peter C; Marshall, Helen S; Nissen, Michael D; Jiang, Qin; Jansen, Kat 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 293 KB

Efficacy, safety, and immunology of an i

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

✍ Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Li, Xiu-Ling; Mao, Qun-Ying; Tao, Ho 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 263 KB